Learn why pharma industry giants choose to work with us

Find out more about why our clients choose to work with us. We are dedicated to providing high-quality services and biomarkers that provide true prognostic and predictive value. With our scientific expertise and extensive experience of over 30 years with biomarker development, we are the leading expert for ECM research.

Nordic biomarker solutions About us

Biomarkers for a range of therapeutic areas

With over a hundred partners and collaborators worldwide, we bring trusted and well-tested expertise in drug development programs, research studies, or joint publication efforts.

Implementing biomarkers on all levels of drug development has been proven to facilitate better and faster drug development, and improve the outcomes of clinical trials. They can reduce the costs associated with clinical trials, thereby benefitting multiple stakeholders including patients, regulators, and drug developers.

With over 100 different types of biomarkers in our portfolio, we provide a variety of biomarker solutions in different therapeutic areas. Besides our commercial assays, we also have a range of our own unique Nordic assays such as nordicPRO-C3™ or nordicPRO-C6™, which also can be purchased as a Kit in a Box. This puts the assay directly into your hands, making it a practical, lab-ready tool for rapid, reproducible results.

Browse our biomarker portfolio

Some of our collaborators and partners

Nordic ProteinFingerPrint Technology™

Nordic Bioscience’s ProteinFingerPrint Technology™ is backed by more than 30 years of research and used by world-leading pharmaceutical companies. Our extracellular matrix-based approach quantifies disease activity with precision unmatched by omics providers, offering mechanistic and pharmacodynamic insights into tissue remodeling, a process crucial to understand when evaluating the effect of a therapeutic intervention.

The Nordic ProteinFingerPrint™ non-invasive and pharmacodynamic biomarkers provide more precise identification of the mechanism of action, patients to treat, or the patient population that will benefit the most from personalized treatments. This enables researchers to develop targeted strategies, gain insights into disease mechanisms and monitor disease progression.

Find out more about our Nordic ProteinFingerPrint Technology™

CAP/CLIA certified lab

At Nordic Bioscience Laboratory, our top priority is to provide the highest quality laboratory services with a focus on data integrity, customer satisfaction and scientific excellence. We offer both central and specialty lab services, as well as diagnostic and exploratory test validation, and have the expertise and experience to meet specific needs.

Our clinical laboratory is certified under the guidelines of the College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA). All of our laboratory services are performed in accordance with the international standards of Good Clinical Practice (GCP) and Good Clinical Laboratory Practices (GCLP).

Our experience and expertise

We have more than 30 years of experience in the biomarker development field, and continuously strive to create new unique biomarkers that can enrich clinical trials with valuable insights. By working closely together with our pharma and biotech clients, we can identify projects suitable for clinical development using our unique Nordic ProteinFingerPrint Biomarker Technology™. We are actively involved in every phase of drug development – financially, scientifically, and operationally. This gives our clients a level of security, trust and insights when working together with us.

We are research-driven and have published 750+ peer-reviewed publications, which underlines our scientific interest and contributions. It is important to us to continuously grow, learn and adapt our biomarker solutions to the recent research.

Browse our knowledge hub